Abstract
Background: Prior authorizations (PA) are used by insurers to control health care costs by requiring providers to obtain approval before specific pharmaceuticals and/or medical services can be used. This process is often used for expensive therapies and limits plan members’ access with the goal to reduce health expenditures. Although initially used to promote lower-cost, but equally effective alternatives, it has become overused to the point where it is now a burdensome and time-consuming task, which diverts resources away from direct patient care to administrative duties.
Original language | English (US) |
---|---|
Pages (from-to) | 1087-1088 |
Number of pages | 2 |
Journal | Journal of Allergy and Clinical Immunology: In Practice |
Volume | 11 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2023 |
Keywords
- AAAAI position statements
- Prior authorization
ASJC Scopus subject areas
- Immunology and Allergy